PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions

Heart Valve DiseasesMitral Valve DiseaseAortic Valve DiseaseTricuspid Valve Disease

Trial Locations (1)

RECRUITING

University Heart and Vascular Center Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg

All Listed Sponsors

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER